Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects

Experimental Neurology - Tập 234 - Trang 506-512 - 2012
Stuart Viegas1, Leslie Jacobson1, Patrick Waters1, Judith Cossins1, Saiju Jacob1, M. Isabel Leite1, Richard Webster1, Angela Vincent1
1Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford OX3 9DS, UK

Tài liệu tham khảo

Burges, 1990, A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro, Muscle Nerve, 13, 407, 10.1002/mus.880130507 Burges, 1994, Passive transfer of seronegative myasthenia gravis to mice, Muscle Nerve, 17, 1393, 10.1002/mus.880171208 Cole, 2008, Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction, Ann. Neurol., 63, 782, 10.1002/ana.21371 Cole, 2010, Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice, J. Physiol., 588, 3217, 10.1113/jphysiol.2010.190298 Cossins, 2004, A mouse model of AChR deficiency syndrome with a phenotype reflecting the human condition, Hum. Mol. Genet., 13, 2947, 10.1093/hmg/ddh320 DeChiara, 1996, The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo, Cell, 85, 501, 10.1016/S0092-8674(00)81251-9 Drachman, 1978, Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation, N. Engl. J. Med., 298, 1116, 10.1056/NEJM197805182982004 Engel, 1977, Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations, Mayo Clin. Proc., 52, 267 Evoli, 2003, Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis, Brain, 126, 2304, 10.1093/brain/awg223 Fambrough, 1973, Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors, Science, 182, 293, 10.1126/science.182.4109.293 Farrugia, 2006, Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis, Muscle Nerve, 33, 568, 10.1002/mus.20491 Hoch, 2003, Molecular dissection of neuromuscular junction formation, Trends Neurosci., 26, 335, 10.1016/S0166-2236(03)00131-0 Hoch, 2001, Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies, Nat. Med., 7, 365, 10.1038/85520 Ito, 1978, Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis, Brain, 101, 345, 10.1093/brain/101.2.345 Jermy, 1993, Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice, Eur. J. Immunol., 23, 973, 10.1002/eji.1830230433 Jha, 2006, Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK), J. Neuroimmunol., 175, 107, 10.1016/j.jneuroim.2006.03.016 Kong, 2004, Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference, EMBO Rep., 5, 183, 10.1038/sj.embor.7400065 Leite, 2008, IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis, Brain, 131, 1940, 10.1093/brain/awn092 McConville, 2004, Detection and characterization of MuSK antibodies in seronegative myasthenia gravis, Ann. Neurol., 55, 580, 10.1002/ana.20061 Niks, 2011, Pre- and postsynaptic neuromuscular junction abnormalities in MuSK myasthenia, Muscle Nerve, 42, 283, 10.1002/mus.21642 Patrick, 1973, Autoimmune response to acetylcholine receptor, Science, 180, 871, 10.1126/science.180.4088.871 Plomp, 1995, Acetylcholine release in myasthenia gravis: regulation at single end-plate level, Ann. Neurol., 37, 627, 10.1002/ana.410370513 Punga, 2011, Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice, Exp. Neurol., 230, 207, 10.1016/j.expneurol.2011.04.018 Rodgaard, 1987, Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3, Clin. Exp. Immunol., 67, 82 Shigemoto, 2006, Induction of myasthenia by immunization against muscle-specific kinase, J. Clin. Invest., 116, 1016, 10.1172/JCI21545 Shiraishi, 2005, Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis, Ann. Neurol., 57, 289, 10.1002/ana.20341 ter Beek, 2009, The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates, Am. J. Pathol., 175, 1536, 10.2353/ajpath.2009.090040 Toyka, 1975, Myasthenia gravis: passive transfer from man to mouse, Science, 190, 397, 10.1126/science.1179220 Vincent, 1982, Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles, Clin. Exp. Immunol., 49, 257 Wood, 2001, Safety factor at the neuromuscular junction, Prog. Neurobiol., 64, 393, 10.1016/S0301-0082(00)00055-1